01349 FUDANZHANGJIANG
- 2.290
- -0.030-1.29%
FUDANZHANGJIANG News
FUDANZHANGJIANG: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024
FUDANZHANGJIANG: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
FUDANZHANGJIANG: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024
FUDANZHANGJIANG: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
FUDANZHANGJIANG: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
FUDANZHANGJIANG: INDICATIVE ANNOUNCEMENT-OBETICHOLIC ACID TABLETS FOR THE TREATMENT OF PRIMARY BILIARY CHOLANGITIS RECEIVED THE ACCEPTANCE NOTICE FOR THE ABBREVIATED NEW DRUG APPLICATION
FUDANZHANGJIANG: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
FUDANZHANGJIANG: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024
FUDANZHANGJIANG: INDICATIVE ANNOUNCEMENT-FIRST PATIENT ENROLLED IN PHASE II CLINICAL TRIAL IN THE UNITED STATES OF HEMOPORFIN FOR INJECTION FOR THE TREATMENT OF PORT WINE BIRTHMARK
FUDANZHANGJIANG: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
FUDANZHANGJIANG: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024
FUDANZHANGJIANG: INDICATIVE ANNOUNCEMENT-FIRST PATIENT ENROLLED IN PHASE III CLINICAL TRIAL OF FDA018 ANTIBODY DRUG CONJUGATE FOR INJECTION FOR THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER
FUDANZHANGJIANG: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
FUDANZHANGJIANG: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
FUDANZHANGJIANG: INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2024
FUDANZHANGJIANG: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
FUDANZHANGJIANG: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
FUDANZHANGJIANG: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
FUDANZHANGJIANG: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
FUDANZHANGJIANG: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024
No Data